Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Potential of Neuraminidase from Pasteurella multocida for Inhibiting Avian Influenza Virus Subtype H9N2 Replication In Ovo

Tropical Animal Science Journal · Vol. 46 No. 4 (2023) · hlm. 487–493

DOI
10.5398/tasj.2023.46.4.487
ISSN
2615-790X, 2615-787X
Terbit
2023-12-03
Penerbit
Faculty of Animal Science, IPB University
Bahasa
eng

Abstrak

In recent decades, neuraminidase/sialidase-based antivirals have been produced to suppress respiratory viral infections, including avian influenza, which relies on sialic acid as the entry point for viruses into cells. While neuraminidase has been extensively studied as an antiviral agent, numerous neuraminidases still have not been evaluated for their antiviral activities. Among these is NanB neuraminidase derived from Pasteurella multocida, which has received limited research attention. This study aimed to assess the potential of NanB neuraminidase in inhibiting H9N2 avian influenza virus infection in ovo. The research commenced with the molecular re-identification of the H9N2 A/Layer/Indonesia/WestJava-04/17 virus isolate, followed by determining the EID50 through Rapid HA test results. The toxicity of NanB neuraminidase was assessed by administering various doses to embryonated chicken eggs (ECE). The antiviral activity of NanB neuraminidase on ECE was evaluated through challenge tests, including treatment before, during, and after the challenge. The assessment involved monitoring the time of embryo death, virus titer through HA test, and viral copy number via RT-qPCR. The results indicated that the H9N2 virus titers capable of infecting 50% of ECE amounted to 108.83 EID50/mL. A dose of 0.258 U/mL of NanB neuraminidase was found to be toxic, leading to embryo mortality after 48 hours of incubation at 37 ℃, while a non-toxic dose was determined to be 0.129 U/mL. The post-challenge treatment group exhibited the most significant reduction in virus titer in ECE. Notably, NanB neuraminidase derived from P. multocida demonstrated the ability to inhibit H9N2 avian influenza virus infection in the ovo model, with the optimal dosage of 0.129 U/mL. The observed decrease in virus titers in the hemagglutination assay and viral copy number assays suggests that NanB neuraminidase holds promise as a potential antiviral candidate for therapeutic approach.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 189 tautan kepenulisan bersama · 98 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • IPB University
  • National Research and Innovation Agency
  • University of Indonesia
  • Diponegoro University
  • Wageningen University & Research
  • Gomal University
  • Pusat Penelitian dan Pengembangan Peternakan
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Aswin Rafif KhairullahNational Research and Innovation Agency2
Saifur RehmanGomal University2
S. C. KurniawanWageningen University & Research2
Mokhamad Fakhrul UlumIPB University1
Zhi Yien TanIPB University1
. DARMINTOAfiliasi tidak diketahui1
Ni Luh Putu Indi DharmayantiPusat Penelitian dan Pengembangan Peternakan1
Fera IbrahimAfiliasi tidak diketahui1
Hessy NovitaNational Research and Innovation Agency1
Setiadi SetiadiUniversitas Gadjah Mada1
Sapto AndriyonoUniversitas Airlangga1
Siti Nur JannahDiponegoro University1
Nunak NafiqohNational Research and Innovation Agency1
Lila GardeniaNational Research and Innovation Agency1
Dian OktavianiNational Research and Innovation Agency1
Angela Mariana LusiastutiNational Research and Innovation Agency1
ElmanavieanAfiliasi tidak diketahui1
Tanjung PenataseputroNational Research and Innovation Agency1
Siti Gusti NingrumUniversitas Wijaya Kusuma Surabaya1
Dewi SyahidahNational Research and Innovation Agency1
Muhammad Subhan WattiheluwMinistry of Marine Affairs and Fisheries1
Uni PurwaningsihNational Research and Innovation Agency1
Muhammad Choirul HidajatNational Research and Innovation Agency1
Dodi SafariEijkman Institute for Molecular Biology1
Muhammad Hussein GasemDiponegoro University1
Farida Dwi HandayaniUniversity of Indonesia1
Lisa NovipuspitasariAfiliasi tidak diketahui1
Ahmed AhmedAmsterdam University Medical Centers1
Fachriyan Hasmi PasaribuIPB University1
Titis WulandariIPB University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://journal.ipb.ac.id/index.php/tasj/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 10 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Potential of Neuraminidase from Pasteurella multocida for Inhibiting Avian Influenza Virus Subtype H9N2 Replication In Ovo</dc:title>
	<dc:creator xml:lang="en">Poetri, O. N.</dc:creator>
	<dc:creator xml:lang="en">Nugroho, C. M. H.</dc:creator>
	<dc:creator xml:lang="en">Silaen, O. S. M.</dc:creator>
	<dc:creator xml:lang="en">Kurnia, R. S.</dc:creator>
	<dc:creator xml:lang="en">Krisnamurti, D. G. B.</dc:creator>
	<dc:creator xml:lang="en">Indrawati, A.</dc:creator>
	<dc:creator xml:lang="en">Hikmah, N.</dc:creator>
	<dc:creator xml:lang="en">Hariyadi, I. P. P. K.</dc:creator>
	<dc:creator xml:lang="en">Putra, M. A.</dc:creator>
	<dc:creator xml:lang="en">Soebandrio, A.</dc:creator>
	<dc:subject xml:lang="en">antiviral</dc:subject>
	<dc:subject xml:lang="en">H9N2</dc:subject>
	<dc:subject xml:lang="en">in ovo</dc:subject>
	<dc:subject xml:lang="en">NanB neuraminidase</dc:subject>
	<dc:subject xml:lang="en">Pasteurella multocida</dc:subject>
	<dc:description xml:lang="en">In recent decades, neuraminidase/sialidase-based antivirals have been produced to suppress respiratory viral infections, including avian influenza, which relies on sialic acid as the entry point for viruses into cells. While neuraminidase has been extensively studied as an antiviral agent, numerous neuraminidases still have not been evaluated for their antiviral activities. Among these is NanB neuraminidase derived from Pasteurella multocida, which has received limited research attention. This study aimed to assess the potential of NanB neuraminidase in inhibiting H9N2 avian influenza virus infection in ovo. The research commenced with the molecular re-identification of the H9N2 A/Layer/Indonesia/WestJava-04/17 virus isolate, followed by determining the EID50 through Rapid HA test results. The toxicity of NanB neuraminidase was assessed by administering various doses to embryonated chicken eggs (ECE). The antiviral activity of NanB neuraminidase on ECE was evaluated through challenge tests, including treatment before, during, and after the challenge. The assessment involved monitoring the time of embryo death, virus titer through HA test, and viral copy number via RT-qPCR. The results indicated that the H9N2 virus titers capable of infecting 50% of ECE amounted to 108.83 EID50/mL. A dose of 0.258 U/mL of NanB neuraminidase was found to be toxic, leading to embryo mortality after 48 hours of incubation at 37 ℃, while a non-toxic dose was determined to be 0.129 U/mL. The post-challenge treatment group exhibited the most significant reduction in virus titer in ECE. Notably, NanB neuraminidase derived from P.&amp;nbsp;multocida demonstrated the ability to inhibit H9N2 avian influenza virus infection in&amp;nbsp;the ovo model, with the optimal dosage of 0.129 U/mL. The observed decrease in virus titers in the hemagglutination assay and viral copy number assays suggests that NanB neuraminidase holds promise as a potential antiviral candidate for therapeutic approach.</dc:description>
	<dc:publisher xml:lang="en">Faculty of Animal Science, IPB University</dc:publisher>
	<dc:date>2023-12-03</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.ipb.ac.id/tasj/article/view/47088</dc:identifier>
	<dc:identifier>10.5398/tasj.2023.46.4.487</dc:identifier>
	<dc:source xml:lang="en">Tropical Animal Science Journal; Vol. 46 No. 4 (2023): Tropical Animal Science Journal; 487-493</dc:source>
	<dc:source>2615-790X</dc:source>
	<dc:source>2615-787X</dc:source>
	<dc:source>10.5398/tasj.2023.46.4</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.ipb.ac.id/tasj/article/view/47088/26767</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2023 Tropical Animal Science Journal</dc:rights>
</oai_dc:dc>